Κατεύθυνση Καρκίνος Πνεύμονα: Σύγχρονη Κλινικοεργαστηριακή Προσέγγιση και Έρευνα
Library of the School of Health Sciences

2018-12-12

2018

Cholidou Kyriaki

Πέτρος Μπακάκος, Αναπληρωτής Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Κωνσταντίνος N. Συρίγος, Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Ιωάννης Γκιόζος, Διδάκτωρ, Ιατρική Σχολή, ΕΚΠΑ

Προγνωστική αξία του μέσου όγκου αιμοπεταλίων (MPV) στην επιβίωση ασθενών με καρκίνο πνεύμονα

English
Greek

Predictive value of mean platelet volume (MPV) in the survival of lung cancer patients

Lung cancer is the most common and most deadly cancer in the world. In Greece, lung cancer is the most common cancer in men and the second most frequent cancer in women. Each year more than 5,000 people are affected by lung cancer. Its frequency is rising rapidly due to the increase in smokers in recentdecades.
Lung cancer is predominantly attributable to smoking and the risk of developing it to a smoker is 10-30 times greater than that of a non-smoker. Histologically it is divided into two types, small cell (15%) and non-small cell (85%) lung cancer. Non-small cell is divided into three major subcategories, adenocarcinoma, squamous cell carcinoma and large cell carcinoma.
The present study is a retrospective analysis of the prognostic value of mean platelet count (MPV) in the survival of patients suffering from lung cancer. A total number of 30 patients with non-small cell lung cancer was studied and the average age of the patients was 68.5 years and 90% of them were active or ex-smokers (45%). Also, we found that the higher the average platelet volume, the greater the survival of the patient.

Health Sciences

Mean platelet volume, Lung cancer

No

0

Yes

169

135

File access is restricted only to the intranet of UoA.

https://pergamos.lib.uoa.gr/uoa/dl/object/2837578